Cas:59137-36-9 4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile manufacturer & supplier

Chemical Name:4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile

CAS.NO:59137-36-9

Synonyms:4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile

Molecular Formula:C₁₈H₁₉N

Molecular Weight:249.35000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:388.8ºC at 760 mmHg

Density:1.02g/cm3

Index of Refraction:1.567

PSA:23.79000

Exact Mass:249.15200

LogP:4.81388

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile Use and application,4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile technical grade,usp/ep/jp grade.

Related News: He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. 4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile manufacturer In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements. 4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile supplier Hong Kong confirmed its 14th coronavirus case late Saturday. The patient, an 80-year-old man, had traveled for a few hours to mainland China in early January, and later spent several days on a cruise ship in Japan with more than 3,000 passengers and employees. 4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile vendor The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. 4′-[(2S)-2-Methylbutyl]-4-biphenylcarbonitrile factory In a statement to Fierce Medtech, Innova said it has completed some corrective actions, while others are still underway, and that the U.S. recall was launched to reclaim tests distributed to employees, clinical studies and to customers for early evaluation. The company said it plans to seek an emergency use authorization and comply with all FDA requirements.